Shandong Xinhua Pharmaceutical (000756.SZ) obtained the drug registration certificate for Levocarnitine Oral Solution.

Shandong Xinhua Pharmaceutical (000756.SZ) announced that recently, the company received the "Drug Registration Certificate" for Levocarnitine Oral Solution (hereinafter referred to as "this product") approved and issued by the National Medical Products Administration. This product is used for the treatment of primary systemic carnitine deficiency. In reported cases, clinical manifestations include recurrent Reye-like encephalopathy, hypoketotic hypoglycemia, and/or cardiomyopathy.